Pesticides in Honey Bee Colonies: establishing a baseline for real world exposure over seven years in the USA

2021 ◽  
pp. 116566
Author(s):  
Kirsten S. Traynor ◽  
Simone Tosi ◽  
Karen Rennich ◽  
Nathalie Steinhauer ◽  
Eva Forsgren ◽  
...  
Keyword(s):  
The Usa ◽  
Author(s):  
J. L. Kevill ◽  
K. C. Stainton ◽  
D. C. Schroeder ◽  
S. J. Martin

AbstractDeformed wing virus (DWV) has been linked to the global decline of honey bees. DWV exists as three master variants (DWV-A, DWV-B, and DWV-C), each with differing outcomes for the honey bee host. Research in the USA showed a shift from DWV-A to DWV-B between 2010 to 2016 in honey bee colonies. Likewise, in the UK, a small study in 2007 found only DWV-A, whereas in 2016, DWV-B was the most prevalent variant. This suggests a shift from DWV-A to DWV-B might have occurred in the UK between 2007 and 2016. To investigate this further, data from samples collected in 2009/10 (n = 46) were compared to existing data from 2016 (n = 42). These samples also allowed a comparison of DWV variants between Varroa-untreated (feral) and Varroa-treated (managed) colonies. The results revealed that, in the UK, DWV-A was far more prevalent in 2009/10 (87%) than in 2016 (43%). In contrast, DWV-B was less prevalent in 2009/10 (76%) than in 2016 (93%). Regardless if colonies had been treated for Varroa (managed) or not (feral), the same trend from DWV-A to DWV-B occurred. Overall, the results reveal a decrease in DWV-A and an increase in DWV-B in UK colonies.


EDIS ◽  
2020 ◽  
Vol 2020 (1) ◽  
pp. 7
Author(s):  
Catherine M. Mueller ◽  
Cameron Jack ◽  
Ashley N. Mortensen ◽  
Jamie D. Ellis

European foulbrood is a bacterial disease that affects Western honey bee larvae. It is a concern to beekeepers everywhere, though it is less serious than American foulbrood because it does not form spores, which means that it can be treated. This 7-page fact sheet written by Catherine M. Mueller, Cameron J. Jack, Ashley N. Mortensen, and Jamie Ellis and published by the UF/IFAS Entomology and Nematology Department describes the disease and explains how to identify it to help beekeepers manage their colonies effectively and prevent the spread of both American and European foulbrood.https://edis.ifas.ufl.edu/in1272


2021 ◽  
Vol 160 (6) ◽  
pp. S-263-S-264
Author(s):  
Olulade Ayodele ◽  
Rohan C. Parikh ◽  
Elizabeth Esterberg ◽  
Mayank Ajmera ◽  
Bridgett Goodwin ◽  
...  

Insects ◽  
2021 ◽  
Vol 12 (7) ◽  
pp. 641
Author(s):  
Julio Chávez-Galarza ◽  
Ruth López-Montañez ◽  
Alejandra Jiménez ◽  
Rubén Ferro-Mauricio ◽  
Juan Oré ◽  
...  

Mitochondrial DNA variations of Peruvian honey bee populations were surveyed by using the tRNAleu-cox2 intergenic region. Only two studies have characterized these populations, indicating the presence of Africanized honey bee colonies in different regions of Peru and varied levels of Africanization, but the current status of its genetic diversity is unknown. A total of 512 honey bee colonies were sampled from three regions to characterize them. Our results revealed the presence of European and African haplotypes: the African haplotypes identified belong to sub-lineage AI (13) and sub-lineage AIII (03), and the European haplotypes to lineages C (06) and M (02). Of 24 haplotypes identified, 15 new sequences are reported here (11 sub-lineage AI, 2 sub-lineage AIII, and 2 lineage M). Peruvian honey bee populations presented a higher proportion from African than European haplotypes. High proportions of African haplotype were reported for Piura and Junín, unlike Lima, which showed more European haplotypes from lineage C. Few colonies belonging to lineage M would represent accidental purchase or traces of the introduction into Peru in the 19th century.


Author(s):  
Njira Lugogo ◽  
Ileen Gilbert ◽  
Joseph Tkacz ◽  
Hitesh Gandhi ◽  
Nadia Goshi ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
William G. Meikle ◽  
John J. Adamczyk ◽  
Milagra Weiss ◽  
Janie Ross ◽  
Chris Werle ◽  
...  

AbstractThe effects of agricultural pesticide exposure upon honey bee colonies is of increasing interest to beekeepers and researchers, and the impact of neonicotinoid pesticides in particular has come under intense scrutiny. To explore potential colony-level effects of a neonicotinoid pesticide at field-relevant concentrations, honey bee colonies were fed 5- and 20-ppb concentrations of clothianidin in sugar syrup while control colonies were fed unadulterated syrup. Two experiments were conducted in successive years at the same site in southern Arizona, and one in the high rainfall environment of Mississippi. Across all three experiments, adult bee masses were about 21% lower among colonies fed 20-ppb clothianidin than the untreated control group, but no effects of treatment on brood production were observed. Average daily hive weight losses per day in the 5-ppb clothianidin colonies were about 39% lower post-treatment than in the 20-ppb clothianidin colonies, indicating lower consumption and/or better foraging, but the dry weights of newly-emerged adult bees were on average 6–7% lower in the 5-ppb group compared to the other groups, suggesting a nutritional problem in the 5-ppb group. Internal hive CO2 concentration was higher on average in colonies fed 20-ppb clothianidin, which could have resulted from greater CO2 production and/or reduced ventilating activity. Hive temperature average and daily variability were not affected by clothianidin exposure but did differ significantly among trials. Clothianidin was found to be, like imidacloprid, highly stable in honey in the hive environment over several months.


Author(s):  
Belén Branchiccela ◽  
Loreley Castelli ◽  
Sebastián Díaz-Cetti ◽  
Ciro Invernizzi ◽  
Yamandú Mendoza ◽  
...  

Author(s):  
Annette Rudolph ◽  
Hendrike Dahmke ◽  
Hugo Kupferschmidt ◽  
Andrea Burden ◽  
Stefan Weiler

Abstract Purpose Tizanidine, an alpha-adrenergic substance with antinociceptive and antihypertensive effects, is extensively metabolized via cytochrome P450 (CYP) 1A2. Therefore, coadministration with potent CYP1A2 inhibitors, such as ciprofloxacin, is contraindicated. However, both drugs are broadly utilized in various countries. Their concomitant use bears an inherent high risk for clinically significant symptoms, especially in multimorbid patients experiencing polypharmacy. This study aims to investigate the impact of coadministration of tizanidine and ciprofloxacin using real-world pharmacovigilance data and to raise awareness of this potentially underestimated safety issue. Methods We conducted a retrospective study including Individual Case Safety Reports (ICSR) registered until March 1, 2017, in the World Health Organization (WHO) global database. Demographic data, drug administration information, the course of the adverse drug reaction (ADR), its severity, and outcomes were analyzed for cases reporting ciprofloxacin comedication. Results In 91 (2.0%) of the identified 4192 worldwide ICSR on tizanidine, coadministration of ciprofloxacin was reported. Most of the patients were female (n = 59, 64.8%) with a median age of 54 years (range 13–85 years). The countries contributing most reports were the USA (n = 54, 59.3%) and Switzerland (n = 16, 17.6%). ADRs reported most often affected the nervous system and the cardiac function, especially with large tizanidine doses or drugs with CNS and cardiovascular depressant effects. In two cases, a fatal outcome was reported. Conclusion Despite the existing formal contraindication, the concomitant use of tizanidine and ciprofloxacin can be observed in real-world clinical practice. Reactions mainly affected the central nervous and the cardiovascular system resulting in potentially severe adverse effects. The concomitant use of tizanidine and ciprofloxacin should absolutely be avoided.


Sign in / Sign up

Export Citation Format

Share Document